# Re-induction of a Systemic Immune Response in Metastatic or Locally Recurrent Lung Cancer

> **NCT06024941** · PHASE2 · WITHDRAWN · sponsor: **Maastricht Radiation Oncology**

## Conditions studied

- Lung Cancer Stage IV

## Interventions

- **RADIATION:** Radiation

## Key facts

- **NCT ID:** NCT06024941
- **Lead sponsor:** Maastricht Radiation Oncology
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2024-12-01
- **Primary completion:** 2025-12-01
- **Final completion:** 2026-12-01
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Submission not finished
- **Last updated:** 2024-09-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06024941

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06024941, "Re-induction of a Systemic Immune Response in Metastatic or Locally Recurrent Lung Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06024941. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*